移植患者的葡萄糖代谢,有或没有移植后糖尿病:关注β细胞功能
Amelie Kurnikowski1, Benedetta Salvatori2, Michael Krebs3
1Department of Epidemiology, Center for Public Health, Medical University of Vienna, 1090 Vienna, Austria.
Biomedicines
|February 24, 2024
概括
移植后糖尿病 (PTDM) 在移植后很常见. 这项研究发现,PTDM的主要问题是严重的β细胞损伤,而不是胰岛素耐药性,这表明治疗的重点是胰岛素分泌.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内分泌学 在内分泌学.
- 代谢研究研究 代谢研究
背景情况:
- 移植后糖尿病 (PTDM) 是移植后的一个常见并发症.
- 在PTDM贝塔细胞功能障碍与胰岛素抵抗的主要病理生理缺陷仍在争论中.
研究的目的:
- 为了比较葡萄糖代谢,特别是贝塔细胞功能和胰岛素耐药性,在移植接受者和没有PTDM.
主要方法:
- 从一项随机对照试验中对191名患者进行分析,这些患者在移植后6个月接受了口服葡萄糖耐受性测试 (OGTT).
- 评估贝塔细胞功能和胰岛素耐药性参数的基本指数和数学建模.
主要成果:
- 患有PTDM的患者表现出明显受损的β细胞功能,基于模型的葡萄糖敏感性比非PTDM患者低50%以上.
- 在PTDM患者中,胰岛素敏感性也降低了,但比β细胞功能缺陷的程度要小.
- 基本评估和基于模型的评估都表明,严重的β细胞损伤是PTDM中占主导地位的问题.
结论:
- 移植后糖尿病的主要缺陷是严重的β细胞功能障碍.
- 患有PTDM高风险的移植接受者可能受益于针对胰岛素分泌的向疗法,以控制高血糖症.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Hormones Regulating Blood Glucose
3.3K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
3.3K
Oral Hypoglycemic Agents: Biguanides and Glitazones
201
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
201
Carbohydrate Metabolism
11.1K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.1K
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Oral Hypoglycemic Agents: Glinides
154
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
154


